← Evidence map

TrialBMC pulmonary medicine2016

High strength extrafine pMDI beclometasone/formoterol (200/6 μg) is effective in asthma patients not adequately controlled on medium-high dose of inhaled corticosteroids.

Pierluigi Paggiaro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

5 papers cite it

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled itcites it

2 trials

Full record →Abstract, authors, funding and every citing paper · PMID 27938358